Holen Sie sich die Stockscreener-App
6.38
2.74%
-0.18
Handel nachbörslich:
6.25
-0.13
-2.04%
Finanzdaten der Immuneering Corp-Aktie (IMRX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
16.56%
15.48
|
18.56 | 15.27 | 14.91 | 15.33 |
| Operating Income/Loss |
16.56%
-15.48
|
-18.56 | -15.27 | -14.91 | -15.33 |
| Income/Loss From Continuing Operations Before Tax |
16.65%
-15.05
|
-18.05 | -14.60 | -14.08 | -14.31 |
| Income/Loss From Continuing Operations After Tax |
16.65%
-15.05
|
-18.05 | -14.60 | -14.08 | -14.31 |
|
Net Income/Loss
|
16.65%
-15.05
|
-18.05 | -14.60 | -14.08 | -14.31 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
9,800%
35.53
|
0.3589 | 29.84 | 29.65 | 29.37 |
| Diluted Average Shares |
9,800%
35.53
|
0.3589 | 29.84 | 29.65 | 29.37 |
| Basic Earnings Per Share |
28.81%
-0.42
|
-0.59 | -0.49 | -0.47 | -0.49 |
| Diluted Earnings Per Share |
28.81%
-0.42
|
-0.59 | -0.49 | -0.47 | -0.49 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):